Header Logo

Connection

Ian Dunn to Phosphatidylinositol 3-Kinase

Back to Details
This is a "connection" page, showing publications Ian Dunn has written about Phosphatidylinositol 3-Kinase.
Ian Dunn
Connection Strength
0.157
Phosphatidylinositol 3-Kinase
  1. Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial. J Clin Oncol. 2019 03 20; 37(9):741-750.
    View in: PubMed
    Score: 0.157
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.